Autolus Therapeutics (AUTL) Accounts Payables (2017 - 2025)
Historic Accounts Payables for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to $11.0 million.
- Autolus Therapeutics' Accounts Payables rose 67341.33% to $11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 67341.33%. This contributed to the annual value of $2.0 million for FY2024, which is 181165.05% up from last year.
- Autolus Therapeutics' Accounts Payables amounted to $11.0 million in Q3 2025, which was up 67341.33% from $5.4 million recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' Accounts Payables registered a high of $11.0 million during Q3 2025, and its lowest value of -$319000.0 during Q2 2022.
- In the last 5 years, Autolus Therapeutics' Accounts Payables had a median value of $1.1 million in 2024 and averaged $1.8 million.
- In the last 5 years, Autolus Therapeutics' Accounts Payables tumbled by 12850.76% in 2022 and then surged by 181165.05% in 2024.
- Autolus Therapeutics' Accounts Payables (Quarter) stood at $431000.0 in 2021, then grew by 23.2% to $531000.0 in 2022, then crashed by 80.6% to $103000.0 in 2023, then skyrocketed by 1811.65% to $2.0 million in 2024, then soared by 456.98% to $11.0 million in 2025.
- Its Accounts Payables stands at $11.0 million for Q3 2025, versus $5.4 million for Q2 2025 and $4.5 million for Q1 2025.